This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Role of global public sector research in discovering new drugs and vaccines
The Journal of Technology Transfer Open Access 27 April 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information S1 (box)
Details of data and analysis (PDF 255 kb)
Supplementary information S2 (Table)
Origin of orphan and non-orphan new medicines in the EU: 2010–2012 (PDF 202 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lincker, H., Ziogas, C., Carr, M. et al. Where do new medicines originate from in the EU?. Nat Rev Drug Discov 13, 92–93 (2014). https://doi.org/10.1038/nrd4232
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4232
This article is cited by
-
Role of global public sector research in discovering new drugs and vaccines
The Journal of Technology Transfer (2023)
-
Wissenschaftliche Beratung durch nationale und europäische Zulassungsbehörden bei Arzneimitteln für neuartige Therapien
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2015)
-
Outcomes of EMA marketing authorization applications: does partnering have an influence?
Nature Reviews Drug Discovery (2014)